OCM
BIOL

Orion Capital Management’s Biolase, Inc. BIOL Stock Holding History

Orion Capital Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20
Closed -$562 – 449
2023
Q1 		$562 Hold
20
– – ﹤0.01% 447
2022
Q4 		$1.3K Hold
20
– – ﹤0.01% 382
2022
Q3 		$5K Hold
20
– – ﹤0.01% 361
2022
Q2 		$9K Hold
20
– – 0.01% 335
2022
Q1 		$18K Hold
20
– – 0.01% 286
2021
Q4 		$20K Hold
20
– – 0.01% 258
2021
Q3 		$32K Hold
20
– – 0.02% 220
2021
Q2 		$35K Hold
20
– – 0.02% 198
2021
Q1 		$42K Sell
20
-8
-29% -$19.7K 0.03% 175
2020
Q4 		$29K Buy
+28
New +$21.4K 0.02% 190

Other funds holding BIOL

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $3.64B AUM 14.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $2.89B AUM 18.44% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Orion Capital Management's BIOL Position: Q2 2023 in Review

Orion Capital Management sold out of Biolase, Inc. (BIOL) in Q2 2023, closing a stake of 20 shares — an estimated $562 sold.

Orion Capital Management first reported a position in BIOL in Q4 2020 and held it in 10 quarters. The position peaked at $42K in Q1 2021. 25 funds tracked by Wall St. Rank hold BIOL as of Q2 2023.

  • Orion Capital Management reported no remaining Biolase, Inc. position as of Q2 2023 after selling out during the quarter.
  • Orion Capital Management sold 20 Biolase, Inc. shares in Q2 2023, an estimated $562.
  • Orion Capital Management first reported a position in Biolase, Inc. in Q4 2020 and held it in 10 quarters.
  • Orion Capital Management's Biolase, Inc. position peaked at $42K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2023.

Based on Orion Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.